After observing the tumor-promoting effect of USP13 on CRC development in the mouse model, we further examined the expression of USP13, MKK3, and Ki-67 in CRC tissues from patients using immunohistochemistry (IHC). This evidence concerns the gene MAP2K3 and colorectal carcinoma.